NewsSource: EClinCloud

Product Introduction | Scale Management

2 min readEClinCloud Editorial Team
Article illustration

Source: EClinCloud. Author: EClinCloud.

Article illustration


Scales are measurement and assessment tools commonly used in clinical practice and are essential for evaluating disease severity and supporting objective diagnosis and treatment. Compared with other examination methods, scales are simpler and more accurate to use, and have therefore become an important standard for measuring treatment effects in evidence-based medicine research.


Most scales currently used in clinical research are introduced from abroad, creating many pain points and challenges for scale management in domestic clinical trials:

Article illustration


Article illustration


What Services Does EClinCloud Scale Management Include?


01

Due Diligence

● Identification and due diligence

● Identify the appropriate scale version, the required number of copies, and available scale languages

● Copyright confirmation

● Obtain copyright holder details and fees for copyright acquisition

● Advice and recommendations on scale use


Article illustration



02

Copyright Acquisition and Fee Negotiation

● Copyright authorization and licensing

● Rapidly establish contact with the copyright holder

● Obtain copyright permission and receive the original scale

● Track scale copyright updates

● Scales licensed by the copyright holder


Article illustration



03

Translation and Linguistic Validation

● Translation and validation

● Screen scale translation vendors and audit their qualifications

● Conduct scale translation in accordance with cross-cultural adaptation guidelines, including translation, reconciliation, back-translation, and cultural adaptation


Article illustration



04

Scale Delivery

● Provide the original foreign-language scale to the sponsor

● Translated Chinese version of the scale

● Corresponding Certificates of Translation (COTs)

● License authorizing use of the scale for the study


Article illustration



05

Project Management and In-Process Change Management

● Project follow-up and in-process change management

● Execution and management of copyright holder agreements

● Foreign currency payments


Article illustration



Why Choose EClinCloud?

Article illustration


| About EClinCloud |

EClinCloud is a healthcare and life-sciences technology company rooted in China and serving the global market. Guided by its mission of "bringing effective treatments to patients through technological innovation" and driven by science and medicine, it integrates digital technology with life data to build an end-to-end digital clinical trial cloud platform and provide technical solutions for clinical endpoint assessment, helping domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.



Article illustration

Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.